BRINKMANN VOLKER,브링크만, 폴커,KANEIDER NICOLE,카나이더, 니콜레,WIEDERMANN CHRISTIAN J.,비데르만, 크리스티안, 요트.
申请号：
KR1020127019200
公开号：
KR1020120099499A
申请日:
2004.12.17
申请国别(地区):
KR
年份:
2012
代理人:
摘要：
Disclosed is a new use for sphingosine-1-phosphate (S1P) receptor agonists in combination with a second agent, preferably selected from an AMPA receptor agonist, a nootropic agent, a painkiller and an anti-inflammatory agent in the treatment of progressive dementia or brain degenerative diseases.진행성 치매 또는 퇴행성 뇌 질환의 치료에서의, 스핑고신-1-포스페이트 (S1P) 수용체 효능제, 바람직하게는 2-아미노-2-[2-(4-옥틸페닐)에틸]프로판-1,3-디올의 용도를 개시한다.
